XML 133 R112.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-Based Compensation Non-employee Directors Equity Plan (Details 11) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number     32
Allocated Share-based Compensation Expense $ 92,927 $ 66,245 $ 66,488
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 625    
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 384 359  
Director [Member]      
Share-based Compensation Arrangement by Share-based Payment Award      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 16 23 47
Allocated Share-based Compensation Expense $ 1,150 $ 1,550 $ 1,950
Current Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares   32 26
Previous Equity Plan for Non-Employee Directors [Member]      
Share-based Compensation Arrangement by Share-based Payment Award      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares     54
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award      
Allocated Share-based Compensation Expense $ 52,670 $ 45,975 $ 48,263
Restricted Stock [Member] | Director [Member]      
Share-based Compensation Arrangement by Share-based Payment Award      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised   27 39
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 53 45 64
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 8 12